Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Gentian violet is a synthetic antiseptic dye with antifungal and antibacterial properties. It has been used in medicine since the late 19th century as a topical agent for minor skin infections (cuts, scrapes, burns), fungal infections of the skin and mouth (such as thrush), and occasionally for other dermatological conditions. Mechanistically, gentian violet acts by dissociating into ions that penetrate microbial cell walls; its cationic form binds to negatively charged components such as lipopolysaccharides and DNA in bacteria and fungi. This binding disrupts cell function by inhibiting DNA replication and causing mutations or cell death. Gentian violet also exhibits photodynamic activity via free-radical mechanisms and can dissipate membrane potential in microbes leading to respiratory inhibition[2][5]. It is available over-the-counter in various topical formulations.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on gentian violet.